ConductScience.org, home

Paper40971981

Analysis of global, regional and national trends in the burden of soft tissue and other extraosseous sarcomas from 1990 to 2021: A systematic analysis of the global burden of disease study 2021.

Chen X and 4 others. PLoS One, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Analysis of global, regional and national trends in the burden of soft tissue and other extraosseous sarcomas from 1990 to 2021: A systematic analysis of the global burden of disease study 2021. Papers, record 40971981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40971981

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Analysis of global, regional and national trends in the burden of soft tissue and other extraosseous sarcomas from 1990 to 2021: A systematic analysis of the global burden of disease study 2021.
PubMed
Journal
PLoS One
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen XXing
2Zhang ZZhixiong
3Xiang JJiwei
4Xiong RRuliuhttps://orcid.org/0009-0007-3943-477X
5Zhou XXingmaohttps://orcid.org/0009-0001-8229-182X

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SarcomaMajor topic
Global Burden of DiseaseMajor topic
Soft Tissue NeoplasmsMajor topic
Humans
Male
Female
Incidence
Middle Aged
Adult
Disability-Adjusted Life Years
Adolescent
Aged
Child
Young Adult
Child, Preschool
Global Health
Infant

Source PubMed

Download CSV of topics

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13882140699mTc-MDP bone scintigraphy and 18F-FDG PET/CT findings of osteosarcoma with widespread calcified extraskeletal metastases.Rev Esp Med Nucl Imagen Mol (Engl Ed)2024https://conductscience.org/library/papers/38821406PubMed
234819142Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019.Mil Med Res2021https://conductscience.org/library/papers/34819142PubMed
340034600Epidemiological trends and age-period-cohort effects on lip and oral cavity cancer burden across the BRICS from 1992 to 2021.Front Oncol2025https://conductscience.org/library/papers/40034600PubMed
435410227Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data.Respir Res2022https://conductscience.org/library/papers/35410227PubMed
539855015Global, regional and national burden of neuroblastoma and other peripheral nervous system tumors, 1990 to 2021 and predictions to 2035: visualizing epidemiological characteristics based on GBD 2021.Neoplasia2025https://conductscience.org/library/papers/39855015PubMed
640078181Imaging, clinical, and histopathological challenges in diagnosing retroperitoneal extraskeletal osteosarcoma.Front Oncol2025https://conductscience.org/library/papers/40078181PubMed
739294748Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021.Mil Med Res2024https://conductscience.org/library/papers/39294748PubMed
839290907Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021.EClinicalMedicine2024https://conductscience.org/library/papers/39290907PubMed
935522060Twenty years since Joinpoint 1.0: Two major enhancements, their justification, and impact.Stat Med2022https://conductscience.org/library/papers/35522060PubMed
1032275330Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.CA Cancer J Clin2020https://conductscience.org/library/papers/32275330PubMed
1112692111Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.Cancer Epidemiol Biomarkers Prev2003https://conductscience.org/library/papers/12692111PubMed
1240580032Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021.Cancer Control2025https://conductscience.org/library/papers/40580032PubMed
1339059750Global, regional, and national burden and trends analysis of malignant neoplasm of bone and articular cartilage from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021.Bone2024https://conductscience.org/library/papers/39059750PubMed
1440670971Health inequality and the global burden of mesothelioma: insights from the global burden of disease study 2021.BMC Cancer2025https://conductscience.org/library/papers/40670971PubMed
1539720601Global, regional, and national epidemiology of childhood neuroblastoma (1990-2021): a statistical analysis of incidence, mortality, and DALYs.EClinicalMedicine2025https://conductscience.org/library/papers/39720601PubMed
1639979494Disease burden of trachea, bronchus and lung cancer 1990-2021 and global trends projected to 2035.Sci Rep2025https://conductscience.org/library/papers/39979494PubMed
1731565485Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China.Cancer Biol Med2019https://conductscience.org/library/papers/31565485PubMed
1828988646Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.Lancet Oncol2017https://conductscience.org/library/papers/28988646PubMed
1939762371An analysis of extraskeletal osteosarcoma based on the literature.Sci Rep2025https://conductscience.org/library/papers/39762371PubMed
2032842323[Application of Joinpoint regression model in cancer epidemiological time trend analysis].Zhonghua Yu Fang Yi Xue Za Zhi2020https://conductscience.org/library/papers/32842323PubMed

See all 48 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41792370Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1-PD-L1 axis: a multi-omics and clinical validation study.NPJ Precis Oncol2026https://conductscience.org/library/papers/41792370

Source PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
NF14763PubTator's text mininghttps://conductscience.org/library/genes/4763NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
SSX2B727837PubTator's text mininghttps://conductscience.org/library/genes/727837NCBI Gene
SYT16857PubTator's text mininghttps://conductscience.org/library/genes/6857NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40971981

GET https://conductscience.org/api/papers/v1/40971981/references?page=2